Propranolol Production Cost Reports

The report provides a detailed analysis essential for establishing a propranolol production plant. It encompasses all critical aspects necessary for propranolol production, including the cost of propranolol production, propranolol plant cost, propranolol production costs, and the overall propranolol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a propranolol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Propranolol is a non-selective beta-blocker that manages different cardiovascular conditions. It reduces heart rate, myocardial contractility, blood pressure, and renin release while also easing tremor and anxiety-related symptoms. It is FDA-approved for treating hypertension to prevent stroke and heart failure, relieving angina pectoris by decreasing myocardial oxygen demand. It controls atrial fibrillation or flutter, preventing secondary myocardial infarction, and addressing hypertrophic subaortic stenosis to improve outflow obstruction. It prevents migraine headaches, treats essential tremor and thyrotoxicosis symptoms like palpitations, and aids in pheochromocytoma management preoperatively. It is available in immediate-release tablets, extended-release capsules, oral solutions, and injectables.

The market for propranolol is driven by the growing cases of cardiovascular diseases around the globe. Its utilisation in hypertension, arrhythmias, angina, and heart failure, along with ageing populations, contributes to its demand. Its expanding therapeutic applications in migraine prophylaxis, essential tremor management, and anxiety disorders further contribute to its demand. The improved healthcare infrastructure, urbanisation, and rising insurance support its market dynamics. The industrial propranolol procurement is influenced by the presence of generics, supply chain dependencies on key API producers, and regulatory hurdles for new formulations or approvals. Also, competition from alternative therapies and sustained-release innovations further impacts sourcing strategies.

Raw Material for Propranolol Production

According to the propranolol production plant project report, the key raw materials used in the production of propranolol include 1-naphthol and epichlorohydrin.

Production Process of Propranolol

The extensive propranolol production cost report consists of the following major industrial production process:

1. From 1-naphthol and epichlorohydrin: The production process of propranolol involves a two-step synthesis. First, 1-naphthol is deprotonated under basic conditions and reacts with an epichlorohydrin-type precursor to form the glycidyl ether intermediate, 2-((naphthalen-1-yloxy)methyl)oxirane. This epoxide then goes through ring-opening with isopropylamine through nucleophilic attack at the less substituted carbon to give a racemic propranolol (1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol). The product is purified by column chromatography to get propranolol as the final product.

Propranolol is a non-selective beta-blocker with the molecular formula C16H21NO2 and molecular weight of 259.35 g/mol. It appears as a white to off-white, odourless crystalline powder. It has a melting point of 96 degree Celsius with low water solubility. It has a logP value of 2.58 that makes it moderately lipophilic. It has a pKa value of around 9.45 for the amine group, and vapour pressure properties supporting its solid-state stability under ambient conditions. It has a naphthalen-1-yloxy-propan-2-ylamine structure with a chiral centre at the propanol carbon (S-enantiomer more active). It shows membrane-stabilising effects alongside hydrogen bonding capabilities from its hydroxyl and amino groups.